Works matching IS 0008543X AND DT 2004 AND VI 101 AND IP 6

Results: 27
    1
    2

    Breast carcinoma in elderly womenPresented, in part, at the 39th Annual Meeting of the American Society of Clinical Oncology, Chicago, Illinois, May 31‐June 3, 2003.: Features of disease presentation, choice of local and systemic treatments compared with younger postmenopausal patients

    Published in:
    Cancer (0008543X), 2004, v. 101, n. 6, p. 1302, doi. 10.1002/cncr.20535
    By:
    • Roberto Gennari;
    • Giuseppe Curigliano;
    • Nicole Rotmensz;
    • Chris Robertson;
    • Marco Colleoni;
    • Stefano Zurrida;
    • Franco Nolè;
    • Filippo de Braud;
    • Laura Orlando;
    • Maria Cristina Leonardi;
    • Viviana Galimberti;
    • Mattia Intra;
    • Paolo Veronesi;
    • Giuseppe Renne;
    • Saverio Cinieri;
    • Riccardo A. Audisio;
    • Alberto Luini;
    • Roberto Orecchia;
    • Giuseppe Viale;
    • Aron Goldhirsch
    Publication type:
    Article
    3

    XRCC1 and glutathione‐S‐transferase gene polymorphisms and susceptibility to radiotherapy‐related malignancies in survivors of Hodgkin disease: A report from the Childhood Cancer Survivor StudyThe following institutions and investigators participated in the Childhood Cancer Survivor Study (*institutional principal investigator; †former institutional principal investigator; ‡member of the Childhood Cancer Survivor Study Steering Committee): University of California–San Francisco, San Francisco, CA (Arthur Ablin, M.D.*); University of Alabama–Birmingham, Birmingham, AL (Roger Berkow, M.D.*); International Epidemiology Institute, Rockville, MD (John Boice, Sc.D.‡); University of Washington, Seattle, WA (Norman Breslow, Ph.D.‡); University of Texas–Southwestern Medical Center, Dallas, TX (George R. Buchanan, M.D.* and Kevin Oeffinger, M.D.‡); Dana‐Farber Cancer Institute, Boston, MA (Lisa Diller, M.D.,* Holcombe Grier, M.D.† and Frederick Li, M.D.‡); Texas Children's Cancer Center, Housto

    Published in:
    Cancer (0008543X), 2004, v. 101, n. 6, p. 1463, doi. 10.1002/cncr.20520
    By:
    • Ann C. Mertens;
    • Pauline A. Mitby;
    • Gretchen Radloff;
    • Irene M. Jones;
    • John Perentesis;
    • William R. Kiffmeyer;
    • Joseph P. Neglia;
    • Anna Meadows;
    • John D. Potter;
    • Debra Friedman;
    • Yutaka Yasui;
    • Leslie L. Robison;
    • Stella M. Davies
    Publication type:
    Article
    4
    5
    6
    7
    8
    9

    African‐American/White differences in breast carcinomaSee related editorial on pages 1261–3, this issue.Certain data used in the current study were obtained from the Connecticut Tumor Registry located in the Connecticut Department of Public Health. The author(s) assume full responsibility for analyses and interpretation of these data.: p53 Alterations and other tumor characteristics

    Published in:
    Cancer (0008543X), 2004, v. 101, n. 6, p. 1293, doi. 10.1002/cncr.20500
    By:
    • Beth A. Jones;
    • Stanislav V. Kasl;
    • Christine L. Howe;
    • Mary Lachman;
    • Robert Dubrow;
    • Mary McCrea Curnen;
    • Hosanna Soler‐Vila;
    • Alicia Beeghly;
    • Fenghai Duan;
    • Patricia Owens
    Publication type:
    Article
    10

    Author reply.

    Published in:
    Cancer (0008543X), 2004, v. 101, n. 6, p. 1478, doi. 10.1002/cncr.20496
    By:
    • Francis J. Giles
    Publication type:
    Article
    11
    12
    13

    Combination chemotherapy (cyclophosphamide, doxorubicin, and vincristine with continuous‐infusion cisplatin and etoposide) and radiotherapy with stem cell support can be beneficial for adolescents and adults with estheisoneuroblastoma.

    Published in:
    Cancer (0008543X), 2004, v. 101, n. 6, p. 1437, doi. 10.1002/cncr.20471
    By:
    • Yuko Mishima;
    • Eijiro Nagasaki;
    • Yasuhito Terui;
    • Tetsuya Irie;
    • Shunji Takahashi;
    • Yoshinori Ito;
    • Masahiko Oguchi;
    • Kazuyoshi Kawabata;
    • Shinetsu Kamata;
    • Kiyohiko Hatake
    Publication type:
    Article
    14
    15
    16
    17
    18

    Intramammary lymph node metastases are an independent predictor of poor outcome in patients with breast carcinomaThe opinions expressed herein do not necessarily reflect the views of the U.S. Government.This article is a U.S. Government work and, as such, is in the public domain in the United States of America.Presented at the 40th Annual Meeting of the American Society of Clinical Oncology, New Orleans, LA, June 5‐8, 2004

    Published in:
    Cancer (0008543X), 2004, v. 101, n. 6, p. 1330, doi. 10.1002/cncr.20515
    By:
    • Jeannie Shen;
    • Kelly K. Hunt;
    • Nadeem Q. Mirza;
    • Savitri Krishnamurthy;
    • S. Eva Singletary;
    • Henry M. Kuerer;
    • Funda Meric‐Bernstam;
    • Barry Feig;
    • Merrick I. Ross;
    • Frederick C. Ames;
    • Gildy V. Babiera
    Publication type:
    Article
    19
    20
    21
    22
    23
    24

    Decentralization of breast cancer surgery in the United StatesPresented in part at the 25th annual meeting of the Society for General Internal Medicine, Atlanta, Georgia, May 1–5, 2002This study used the linked SEER‐Medicare data base. The interpretation and reporting of these data are the sole responsibilities of the authors

    Published in:
    Cancer (0008543X), 2004, v. 101, n. 6, p. 1323, doi. 10.1002/cncr.20490
    By:
    • Joan M. Neuner;
    • Mary Ann Gilligan;
    • Rodney Sparapani;
    • Purushottam W. Laud;
    • David Haggstrom;
    • Ann B. Nattinger
    Publication type:
    Article
    25
    26
    27